Evidence map›Paper›PMID 29997211›Full record

ArticleJournal of virology2018

Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Nondividing Cells.

Cindy Buffone, Alicia Martinez-Lopez, Thomas Fricke, Silvana Opp, Marco Severgnini, Ingrid Cifola, Luca Petiti, Stella Frabetti, Katarzyna Skorupka, Kaneil K Zadrozny and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Viral interference of nucleocytoplasmic transport.The Journal of biological chemistry · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Cindy BuffoneDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Alicia Martinez-LopezDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Thomas FrickeDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Silvana OppDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Marco SevergniniInstitute for Biomedical Technologies, CNR, Segrate, Milan, Italy.
Ingrid CifolaInstitute for Biomedical Technologies, CNR, Segrate, Milan, Italy.
Luca PetitiInstitute for Biomedical Technologies, CNR, Segrate, Milan, Italy.
Stella FrabettiMolecular Virology and Vaccinology Unit, CNRS UMR 3569, Department of Virology, Institut Pasteur, Paris, France.
Katarzyna SkorupkaDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
Kaneil K ZadroznyDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
Barbie K Ganser-PornillosDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
Owen PornillosDepartment of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
Francesca Di NunzioMolecular Virology and Vaccinology Unit, CNRS UMR 3569, Department of Virology, Institut Pasteur, Paris, France dinunzio@pasteur.fr felipe.diaz-griffero@einstein.yu.edu.
Felipe Diaz-GrifferoDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA dinunzio@pasteur.fr felipe.diaz-griffero@einstein.yu.edu.
Albert Einstein College of Medicine · USUniversity of Virginia · USInstitute of Biomedical Technologies · ITCentre National de la Recherche Scientifique · FRDepartment of Virology · FR

Funding

Role of Cellular Factors in Retroviral Uncoating and Synthesis of Viral DNAR01AI087390 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DIAZ-GRIFFERO, FELIPE · 2010 to 2024
$6.8M
Training in HIV/AIDS Pathogenesis; Basic and Translational ResearchT32AI007501 · NIAID · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 1995 to 2024
$6.6M
Molecular mechanisms of the CA-SP1 switch in HIV assembly and maturationR01AI129678 · NIAID · UNIVERSITY OF VIRGINIA · PI GANSER-PORNILLOS, BARBIE K., PORNILLOS, OWEN · 2017 to 2021
$2.3M
Defining the microtubule motors which drive the uncoating and trafficking of HIVR01AI120956 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI CAMPBELL, EDWARD M, DIAZ-GRIFFERO, FELIPE · 2015 to 2019
$1.6M
Regulation of SAMHD1 antiviral activityR01GM123540 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DIAZ-GRIFFERO, FELIPE · 2016 to 2018
$1.4M
NIAID NIH HHS R01 AI087390NIAID NIH HHS R01 AI120956NIAID NIH HHS R01 AI129678NIAID NIH HHS T32 AI007501NIGMS NIH HHS R01 GM123540
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) displays the unique ability to infect nondividing cells. The capsid of HIV-1 is the viral determinant for viral nuclear import. To understand the cellular factors involved in the ability of HIV-1 to infect nondividing cells, we sought to find capsid mutations that allow the virus to infect dividing but not nondividing cells. Because the interaction of capsid with the nucleoporin protein 153 (Nup153) is important for nuclear import of HIV-1, we solved new crystal structures of hexameric HIV-1 capsid in complex with a Nup153-derived peptide containing a phenylalanine-glycine repeat (FG repeat), which we used to guide structure-based mutagenesis of the capsid-binding interface. HIV-1 viruses with mutations in these capsid residues were tested for their ability to infect dividing and nondividing cells. HIV-1 viruses with capsid N57 substitutions infected dividing but not nondividing cells. Interestingly, HIV-1 viruses with N57 mutations underwent reverse transcription but not nuclear translocation. The mutant capsids also lost the ability to interact with Nup153 and CPSF6. The use of small molecules PF74 and BI-2 prevented the interaction of FG-containing nucleoporins (Nups), such as Nup153, with the HIV-1 core. Analysis of integration sites in HIV-1 viruses with N57 mutations revealed diminished integration into transcriptionally active genes in a manner resembling that of HIV-1 in CPSF6 knockout cells or that of HIV-1-N74D. The integration pattern of the N57 mutant HIV-1 can be explained by loss of capsid interaction with CPSF6, whereas capsid interaction with Nup153 is required for HIV-1 to infect nondividing cells. Additionally, the observed viral integration profiles suggested that integration site selection is a multiparameter process that depends upon nuclear factors and the state of the cellular chromatin.

Indexed as

Cell DivisionMutationActive Transport, Cell NucleusCapsidCell LineGene Knockdown TechniquesHIV-1HumansmRNA Cleavage and Polyadenylation FactorsNuclear PoreNuclear Pore Complex Proteinscleavage factor Im, humanmRNA Cleavage and Polyadenylation FactorsNuclear Pore Complex ProteinsNUP153 protein, humancapsid bindingCPSF6HIV-1HIV integrationHIV nuclear importintegrationnondividing cellsNPCnuclear importNup153

Identifiers

PMID29997211
PMCPMC6146805
OpenAlexW2862430014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.